Marvell Technology has agreed to acquire Lumentum Holdings in an all-stock transaction that the companies and business outlets have described as carrying a reported implied enterprise value of $115 billion. The proposed combination would give each Lumentum shareholder 4.5 Marvell shares for every Lumentum share held, according to Marvell’s Form 8-K.
The transaction is a major bet on the growing role of optical connections in AI data centers, but its unusually long path to closing is as consequential as its headline valuation. The companies expect completion in the first half of 2028, CNBC reported, leaving a roughly 14- to 20-month interval from the November 2026 announcement depending on the eventual closing date.
Why the $115 billion figure can move
The $115 billion number is not a fixed cash purchase price. It is a reported implied enterprise value, a distinction that is particularly important because the merger consideration is a fixed number of Marvell shares rather than a fixed dollar amount. Lumentum investors’ ultimate value will rise or fall with Marvell’s stock price between the signing of the agreement and the closing.
Under the agreement, each outstanding Lumentum common share would convert into 4.5 shares of Marvell common stock, with cash paid only instead of fractional Marvell shares. Yahoo Finance’s account also noted that the reported enterprise-value figure includes debt. Enterprise value is therefore a broader transaction measure than the market value of the stock consideration delivered to Lumentum holders.
The structure shifts a meaningful part of the deal’s economic exposure onto Lumentum shareholders. A stronger Marvell share price would increase the market value of the 4.5-share package; a weaker one would reduce it. That is different from a cash acquisition, where the per-share consideration is set at signing unless the parties renegotiate.
Shareholder votes and approvals set the timetable
The merger agreement was signed Nov. 1, 2026, one day before the proposed deal was publicly reported. Its closing conditions go beyond Lumentum shareholder approval. Marvell shareholders must approve the issuance of shares needed for the transaction and an amendment to Marvell’s charter, while the companies also need an effective Form S-4 registration statement and Nasdaq authorization to list the new Marvell shares.
Regulatory approval is also required. The SEC filing specifically lists expiration or termination of the applicable Hart-Scott-Rodino waiting period among the conditions, alongside other required regulatory clearances. Marvell and Lumentum plan to jointly prepare and file the Form S-4, which will include a joint proxy statement for the respective shareholder meetings.
The agreement’s initial outside date is Nov. 1, 2027. In defined circumstances involving outstanding regulatory approvals, that date can be extended successively to Feb. 1, May 1 and Aug. 1, 2028. The first-half 2028 target reported by CNBC and Yahoo Finance is thus an expectation, not a completed timetable; the contract permits a later endpoint if the specified extension conditions apply.
AI connectivity rationale brings optics into Marvell’s strategy
Marvell supplies semiconductor and data-infrastructure technology, while Lumentum makes optical components. Marvell Chief Executive Matt Murphy and Lumentum Chief Executive Michael Hurlston have framed the transaction as a way to address AI-infrastructure connectivity demand by combining electrical and optical capabilities.
The companies’ thesis centers on optical links, which transmit information as light through fiber and can connect chips, servers and larger computing systems. That is the technical rationale offered for placing Lumentum’s optical portfolio alongside Marvell’s semiconductor operations; it is not a guarantee that the combined company will capture the demand it anticipates.
Governance terms show that Lumentum is expected to retain representation in the combined enterprise. After closing, Marvell is to appoint three Lumentum board designees, subject to Marvell’s reasonable acceptance. The provision gives the target’s side of the merger formal board participation, even though Lumentum shareholders will receive Marvell stock and the surviving public company will be Marvell.
Trading reaction underscored the stock-deal exposure
Initial market reports reflected different points in the trading day rather than an apparent disagreement over the deal’s reception. Yahoo Finance reported that Marvell was down about 3% and Lumentum roughly 4% before the opening bell. CNBC later reported Marvell down 13% and Lumentum down nearly 19% during Monday trading.
Those declines matter more in a fixed-exchange merger than in a cash transaction. Marvell’s share price directly affects the current market value represented by 4.5 shares, while investors also must assess whether the proposed combination can clear its shareholder, listing and regulatory conditions on the timetable the companies have set.